ISM-8969

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameISM-8969
Drug Alias NameISM8969ISM-8969ISM8969/HT-001HT-001HT001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsNerve DegenerationInflammationCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInsilico Medicine LtdShenzhen Hengtai Biotechnology Co., Ltd.InSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsNerve DegenerationInflammationCardiovascular Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A